Literature DB >> 36032596

Perspectives on the Immune System in Sepsis.

Felician Stancioiu1, Bogdan Ivanescu2, Radu Dumitrescu3.   

Abstract

Beyond the modifications shown by the biochemistry labs, profound and ample modifications are seen in septic patients at a molecular level stemming from DNA translation and gene expression, manifested as unique profiles of mRNA (messenger), as well as non-coding, functional RNAs: miRNA (micro) and lncRNAs (long non-coding). Counteracting these modifications requires treatment with pleiotropic molecules and/or combination of molecules and opens the possibility of future treatments with arrays of siRNAs and/or specific panels of small molecules tailored for each patient subpopulation.

Entities:  

Year:  2022        PMID: 36032596      PMCID: PMC9375866          DOI: 10.26574/maedica.2022.17.2.395

Source DB:  PubMed          Journal:  Maedica (Bucur)        ISSN: 1841-9038


  73 in total

1.  Circulating cell death biomarker TRAIL is associated with increased organ dysfunction in sepsis.

Authors:  Edward J Schenck; Kevin C Ma; David R Price; Thomas Nicholson; Clara Oromendia; Eliza Rose Gentzler; Elizabeth Sanchez; Rebecca M Baron; Laura E Fredenburgh; Jin-Won Huh; Ilias I Siempos; Augustine Mk Choi
Journal:  JCI Insight       Date:  2019-05-02

2.  Synergistic effects between catalase inhibitors and modulators of nitric oxide metabolism on tumor cell apoptosis.

Authors:  Katrin Scheit; Georg Bauer
Journal:  Anticancer Res       Date:  2014-10       Impact factor: 2.480

3.  Severity of Sepsis Determines the Degree of Impairment Observed in Circulatory and Tissue-Resident Memory CD8 T Cell Populations.

Authors:  Steven J Moioffer; Derek B Danahy; Stephanie van de Wall; Isaac J Jensen; Frances V Sjaastad; Scott M Anthony; John T Harty; Thomas S Griffith; Vladimir P Badovinac
Journal:  J Immunol       Date:  2021-09-03       Impact factor: 5.426

4.  Calprotectin as an early biomarker of bacterial infections in critically ill patients: an exploratory cohort assessment.

Authors:  Niklas Jonsson; Tom Nilsen; Patrik Gille-Johnson; Max Bell; Claes-Roland Martling; Anders Larsson; Johan Mårtensson
Journal:  Crit Care Resusc       Date:  2017-09       Impact factor: 2.159

Review 5.  Glutathione metabolism in sepsis.

Authors:  Gianni Biolo; Raffaella Antonione; Marcello De Cicco
Journal:  Crit Care Med       Date:  2007-09       Impact factor: 7.598

Review 6.  Sepsis-induced immunosuppression: from cellular dysfunctions to immunotherapy.

Authors:  Richard S Hotchkiss; Guillaume Monneret; Didier Payen
Journal:  Nat Rev Immunol       Date:  2013-11-15       Impact factor: 53.106

7.  Serum lactate is associated with mortality in severe sepsis independent of organ failure and shock.

Authors:  Mark E Mikkelsen; Andrea N Miltiades; David F Gaieski; Munish Goyal; Barry D Fuchs; Chirag V Shah; Scarlett L Bellamy; Jason D Christie
Journal:  Crit Care Med       Date:  2009-05       Impact factor: 7.598

8.  Transcriptional instability during evolving sepsis may limit biomarker based risk stratification.

Authors:  Antonia Kwan; Mike Hubank; Asrar Rashid; Nigel Klein; Mark J Peters
Journal:  PLoS One       Date:  2013-03-27       Impact factor: 3.240

9.  Plasma miRNA-223 correlates with risk, inflammatory markers as well as prognosis in sepsis patients.

Authors:  Xiaoling Wu; Junhui Yang; Li Yu; Ding Long
Journal:  Medicine (Baltimore)       Date:  2018-07       Impact factor: 1.889

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.